Archive for the ‘Medical Reviews’ Category
1st Line Infection Fighter
The infection fighting capabilities of thiocyanates are impressive. Not only do they offer a broad spectrum of antimicrobial activity (active against pokie games online both gram negative casino online uk online casino ?????????? play pokies online casino guide online australia real pokies game royal vegas online australian casinos casino casino internet money and casino pa nett roulette online casino online nl casino casino online kasyno poland les machines casino casino canada online a sous casino francais en casino online bonus online casino casino no deposit online pokies canadian casino with spins slots machine online casino bonuses ligne online slot maschinen gram slots machine ???????? ?????? pokies game positive bacteria) but casino online polska they are also casino online holland effective against viruses, yeasts and fungi – none of which respond to antibiotics. Learn More
An Introduction to the inventor of Curaderm-BEC5
Dr. Bill Elliot Cham
Dr Cham’s scientific background is interesting in that he has been engaged in multiple scientific disciplines. His CV reveals that he has published much work in the field of physiology, biochemistry, iron metabolism, pharmacology, toxicology, lipidology, virology and of course oncology. Dr Cham is well known for his medical publications. I gather that he has been successful in these fields because of his wide range of studies majoring in chemistry, biochemistry and obtaining a doctorate in the school of medicine.
Not many scientists have been able to start from basic research and continue this research to bring the results to a clinical level. Astonishingly Dr Cham has achieved this, not with one, but with three, projects.
The first project was with oncology. Dr Cham discovered that various glycoalkaloids found in the eggplant had anticancer properties. He then identified how and why these naturally occurring glycoalkaloids killed cancer cells but did not harm normal cells. These observations have created worldwide recognition and scientists have since confirmed and extended his research, and indeed, a novel approach to treat cancer has evolved. Dr Cham and colleagues established in clinical studies that Curaderm could effectively treat non melanoma skin cancers. His observations with Curaderm BEC5 were so spectacular that skin specialists (dermatologists) in Australia initially did not believe that Curaderm was that efficacious.
Unperturbed Dr Cham supplied Curaderm BEC5 to ten world renowned hospitals in the UK to conduct double blind randomized Phase III clinical studies for the treatment of non melanoma skin cancers. Subsequent to the Phase III studies an open study with Curaderm BEC5 was conducted at the Royal London Hospital. The investigators of all the Hospital Centres were skin specialists (dermatologists).
In both the Phase III and open studies Curaderm BEC5 was shown to be effective in eradicating non melanoma skin cancers including the invasive forms. In his lectures Dr Cham says that he is satisfied that, casino greece beyond a doubt Curaderm BEC5 effectively treats non melanoma skin slots online cancers.
But hold on, this is not the completed story online no deposit casinos of the glycoalkaloids. Based on the original observations of the anticancer properties of the glycoalkaloids casino on human internal cancer cells and terminal cancers in animals, Dr Cham was approached by a pharmaceutical company for the licensing of this technology. Dr Cham not wanting to impede the progress of science and a possible application of the glycoalkaloids for the treatment of casino internetowe internal cancers agreed to license out play casino the glycoalkaloids technology for internal cancers. Currently an slots online Australian listed pharmaceutical company is conducting clinical trials on patients with terminal cancers. At this stage the results for casino francais online australian casinos bonus internal cancers look aussie online casino very promising. Time will tell whether casino online these glycoalkaloids will also be able to successfully treat casino deutschland internal cancers.
Dr Cham’s inventions, slots covered by another major breakthrough casino uk are currently in the pipeline for possible clinical application for the treatment online casino best of the number one biggest killer in the online casino western society, atherosclerosis. Atherosclerosis is the pokies download build up of fats such as cholesterol slots online within pokies online australia the arteries. When the build up of cholesterol (plaques) reaches a certain stage a heart attack usually occurs.
Dr Cham has online casino developed a system that washes the harmfull fats from blood. The defatted blood is then reintroduced into the patient. The defatted blood contains proteins that then dissolve play pokies the fats from the arterial walls resulting in the best online casino the removal of the plaques. Dr Cham has shown slots online this to be very successful in various casino canada online animal models. He maquinas de slots online has licensed this technology casino online to an American casino online holland NASDAQ listed company who are now carrying out clinical trials on humans at the Washington Hospital.
Using similar casino internet technology as the defatting of cholesterol clogged arteries, Dr Cham was able to show that viruses such as hepatitis B, including HIV which causes AIDS, can be killed by this procedure. Furthermore, the killed viruses stimulate the body’s immune system to the extent, that the killed virus obtained by this unique method of killing these viruses, can be used as a vaccine. Studies on animals such as monkeys with SIV (similar to HIV) infection are showing tremendous promise. Last month (October, 2006) Dr Cham has published an article in a medical specialist journal. He and his colleagues at the Sydney University of Australia have shown that his patented procedure can kill hepatitis B virus and that the killed hepatitis B virus when used as a vaccine offer complete protection when exposed to live hepatitis B virus. It is expected that clinical trials on human infected HIV patients will commence in 2007 in the USA.
Dr Cham has surely selected to study the world’s most devastating medical conditions. Thank goodness he has. He has produced the first cream (Curaderm BEC5) to treat non melanoma skin cancer which is now available throughout the world for the public. With the use of this cream it has been shown that due to effective removal of skin cancers by Curaderm BEC5 people’s eyes and noses were saved. Patients are also claiming that Curaderm BEC5 save their lives.
He has been the pioneer in research which is now undergoing human clinical trials for terminal internal cancers and also atherosclerosis (clogging up of arteries with cholesterol) and it is expected that in 2007 human trials will commence on patients with HIV infections.
Congratulations to Dr Cham for his tireless humanitarian efforts for the good of mankind – what a devoted, humble but brilliant person.
The dermatologists who conducted the Phase III clinical trials with BEC 5 concluded that BEC5 is a topical preparation, which is safe and effective. BEC 5 therapy is ideal for outpatient treatment and is a much needed alternative to surgery for BCC. The clinical trials of BEC5 done by the multi-centers, comprised of application of BEC5 twice daily for eight weeks.
Phase III clinical trials involving ten centers in the United Kingdom were completed in 2002. The general success rate of the glycoalkaloids (BEC) cream was 78 percent. Longer duration therapy with BEC would have resulted in higher success rates. These results were comparable to Clinical Trials 1 & 2 and independent doctor studies into Curaderm previously obtained over the last 20 years.
Clinical Trial Centers and Study Investigators
Dr R Cerio
The Royal London Hospital
Professor A Finlay
University of Wales College of Medicine
Dr R A C Graham-Brown
Leicester Royal Infirmary
Dr J Hawk
St Thomas Hospital
Dr M Rustin
Royal Free Hospital
Dr D L Roberts
Dr P Kersey
Professor C E M Griffiths
Dr L J Cook
St Mary”s Hospital, Portsmouth
Dr G R Sharpe
Royal Liverpool Hospital, Liverpool
By Using Curaderm YOU DO NOT NEED Surgery, Radiotherapy or other Conventional Methods
Plastic surgeons, radiotherapists and dermatologists jointly manage BCCs, which are slow growing, locally invasive malignant skin tumors.
To date such management usually involves surgery. It must also be stressed that the risks of surgical intervention are well known. Moreover, excision of BCC from the facial area often involves reconstructive surgery, which can be both time consuming and costly.
The dermatologists who conducted the Phase III clinical trials with BEC 5 concluded that BEC5 is a topical preparation, which is safe and effective. BEC 5 therapy is ideal for outpatient treatment and is a much needed alternative to surgery for BCC.
Tens of Thousands NO longer need to Loose Skin and Body Parts. Curaderm has Clinical Proven Effectiveness.
Following two decades Dr. Cham”s group first reported the efficacy and safety of BEC01 and Curaderm for the treatment of non malignant and invasive malignant skin cancer, the skin specialists who conducted the clinical trials have realized the true benefits of Curaderm.
Tens of thousands of patients have unnecessarily lost their noses, eyes, ears, and some even their lives, because Curaderm cream was not recommended for use! The definite outcome to having an effective treatment for skin cancer using a cream is now about allowing the general public to benefit from Curaderm real value for patients.
The clinical trial experience has shown that the BEC was safe. Only local skin irritation and erythematic (reddening) occurred during treatment. Success was defined as zero presence of basal cell carcinoma after histological (microscopic) examination of samples removed from the lesion sites by punch biopsy. Two applications per day of casino australia online casino internetowe BEC to the cancer lesions resulted in ?????? ?????? ulceration of the safe online casinos lesion sites slots during casino online australia new no play online pokies speelautomaten deposit online casinos treatment. However, it was observed that post treatment the wound was quickly replenished with casino online greece normal tissue and that residual scarring was minimal.
CLINICAL APPRAISAL play casino online ON RESULTS FROM PHASE III Clinical Trials and OPEN STUDIES FROM ROYAL caca-niqueis LONDON online casino HOSPITAL
Dr Sangeeta Punjabl
MBBS speelautomaten DVD DipNB (Dermatology)
Research Registar, Royal London Hospital
BScFgRCP (Lond) FRCP speelautomaten online (Edin)
Consultant Dermotologist and Senior Lecturer in Dermatopathology
The Dermatology Department at the Royal London Hospital has acted as an approved slots and casino designated center in two clinical trials to australian online pokies determine the safety and slots online efficacy of BEC 5 cream in the treatment of cancerous lesions of the skin. In the first of these, a pivotal canadian casino online double blind randomized study; Royal London recruited, ?? ?????? online casino spiele ???????? ????????? ???????? treated and monitored 21 of the 94 patients. In the second trial, comprising 41 patients, Royal London australian casinos was the sole play online pokies designated centre. This slot machines online trial was an open study, conducted primarily assess the safety of the product. Herewith aussie pokies we summarize our observation on the use, casino holland safety, efficacy, cosmetic result and resource effectiveness of the product.
The Dermatology Department at the Royal London Hospital has acted as an approved casino spiele and designated center in two clinical trials to determine the safety and efficacy of BEC 5 cream in the treatment of cancerous lesions ???????????? ????????? ???????? of the skin. In the first of these, a pivotal double blind randomized study; Royal London slot machines online recruited, treated and monitored 21 of play online pokies australia the 94 patients. In the second trial, comprising 41 patients, Royal London was the sole designated centre. This trial was an casino online poland open study, conducted primarily assess the safety of the product. Herewith we summarize our observation on the use, safety, efficacy, cosmetic result and pokie downloads resource effectiveness of the product.
In our view these results, in the least justify a more ?????? ????????? extensive clinical trial of BEC5 against such cancers. We note in this online pokies no download respect that treatment of the morpheoic form of the affliction is presently confined to surgical removal. We are not slot machines aware of casino netherlands any emerging therapy, for example, photodynamic therapy that has the potential to extend to treatment of other than superficial skin cancers.
Our clinical experience has shown that BEC5 is safe. In the casino online two frequent (twice daily) and prolonged (8 weeks) application of a cream incorporating BEC5 under occlusive dressing resulted only in local skin irritation and erythema. Very few patients under our supervision withdrew from treatment on this account. Hence we consider treatment with BEC5 to be safe therapy.
Furthermore, patient blood and urine was analyzed using very sensitive methods to determine the presence of the BEC5 during and after a standard treatment regime (twice daily for 8 weeks). Such analysis product no evidence of the active pharmaccutical ingredients to BEC5 or their breakdown products Hence, it was concluded that there is no systemic absorption of BEC5. This is extremely important from the clinical perspective and may be contrasted with other topical preparations. For example, 5 fluouracil shows systemic absorption and can prove to toxic when used with large lesions.
Royal London has a large dedicated skin cancer clinic as it is a Skin Cancer Center for the North East Thames Network. This fact, coupled with the results of the first trial, was instrumental on Royal London”s conduct of second open study. Success rates in this open trial paralleled the multi-center efficacy rate of 78%. Success was defined as zero presence of basal cell carcinoma after histological examination of samples extracted from the lesion site by punch biopsy.
We consider that this rate of treatment success more than justifies the physician considering BECs as an alternative to currently predominant treatment such as surgical excision or cryotherapy.
BEC results in ulceration of the lesion site during treatment. However, we have observed that post treatment the wound is quick replenished with normal tissue and that residual scarring is minimal. Whether, such scarring proves more or less extensive than that consequent upon a number of factors including lesion size, location and so on. However, it can be said that the cosmetic results offered by treatment with BEC5 are comparable to that resulting from surgical excision.
Basal Cell Carcinoma is a slow growing locally invasive malignant skin tumor which mainly affects Caucasians. Dermatologists, plastic surgeons and radiotherapists jointly manage the affliction, such management usually involves surgery. The risks of surgical intervention are well known.
Moreover, excision of basal cell carcinoma from the facial area often involves reconstructive; which can be both time consuming and costly. Hence an alternative, safe and efficacious method of treatment of basal cell carcinoma that does not require physician or hospital attendance must be encouraged.
In our view and experience BEC5 is a tropical preparation, which is safe and effective, ideal therapy for outpatient treatment. Hence BEC5 is a much needed alternative to surgery for basal cell carcinoma. This is the commonest cancers in Caucasians worldwide and the prevalence continues to increase with an increasing ageing population.
It is a cost effective treatment for both primary and secondary skin cancer care.
1995 (Vol. 6, No.3, September, 1995, Mountain Home Publishing, USA) by Dr David G Williams
Skin Cancer is no stranger to those who live in the southern part of the United States, and especially retirement areas, where the large percentage of people are over the age of 65. Doctors practicing dermatology in these areas are overwhelmed with a constant flow of patients. Patients could wait for weeks to get an appointment with the doctor and within a 5 to 10 minute visit, a skin lesion can often be jacked up in price.
This same scenario occurred in Australia back in 1987. Dr. Bill Cham, a medical researcher and biochemist from Queensland, Australia. A veterinarian in the early 1980�s told Dr. Cham that the juice from the Kangaroo Apple could stop the growth of cancer around the eyes of cattle.
Curious, Dr. Cham began to experiment with various extracts from the Kangaroo Apple growing in his yard. Better known as Solanum sodomaeum, along with numerous other plants and fruits from the solanum species contain steroidal alkaloid glycosides or glycoalkaloids.
As early as ?????? 1825, it was casino online play casino reported that best online casino extracts from pokie machine the plant species, play pokies Solanum, could be effective in the treatment of en ligne casino france cancer.2 In the early 1800�s, like ?????? ?????? today, natural plant remedies were online slot casino internet maschinen not very glamorous or attractive to those who did research funding. Consequently, research australia online casino on the potential of this derivative was not pursued aggressively.
For five years, pokies online games Dr. Cham tested and retested his glycoalkaloid-containing cream on both automaty online laboratory and test animals. He discovered that a glycoalkaloid treatment online casino he had casino developed was able to kill skin cancer cells in the laboratory. He then experimented to find a vehicle that would act as a messenger casino to carry this glycaolkaloid into slot maschinen the deeper layer of casino internet the skin where casino spiele online the cancer cells live and reproduce.
Dr. Cham discovered a way to alter the base by using casino na internet a mucopolysaccharide slots online (a polysaccharide that formed a chemical bond with water to produce lubricating fluids). Thus, Curaderm was created.
Curaderm is 99.8% natural with a tiny amount of preservative added. The active cancer destroying agent is solasodine glycosides, 0.005%. Solasodine is derived from the “Kangaroo Apple” and is in the same family as eggplant. Another well known ingredient is melaleuca oil, 0.1%, which is an anti-microbial from “tea tree”. Linoleic acid, 0.05%, a polyunsaturated fat found in canola oil is present as well. Urea, 5% is to increase the amount of water in the skin. As the cancer cells die, they are encouraged to slough off by the action of salicylic acid at 10%.
Dr, Cham has conducted human studies involving keratoses, basal cell carcinoma, squamous cell carcinomas and other skin lesions. All studies showed a regression of 100% of the skin lesions. Specifically, a Curaderm study was conducted and referenced in the (Cancer Lts 91;59:183-192.) Dr. Cham patented the process for producing his cream and continued his research for five years before he released the results. Many of his patients have been cancer-free for 10 years or more.